-
1.发明申请Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases 有权抗胆碱能药和白细胞三烯受体拮抗剂的组合用于治疗呼吸系统疾病公开(公告)号：US20060211729A1
公开(公告)日：2006-09-21
申请号：US11376615
申请日：2006-03-16
申请人： Beatrix Fyrnys , Torsten Hoffmann , Mario Weingart , Istvan Szelenyi , Peter Cnota , Ullrich Munzel , Ursula Petzold , Joachim Maus
发明人： Beatrix Fyrnys , Torsten Hoffmann , Mario Weingart , Istvan Szelenyi , Peter Cnota , Ullrich Munzel , Ursula Petzold , Joachim Maus
IPC分类号： A61K31/47 , A61K31/4015
CPC分类号： A61K31/40 , A61K31/4015 , A61K31/47 , A61K45/06 , A61K2300/00
摘要： Pharmaceutical compositions comprising an anticholinergic and at least one leukotriene inhibitor for treatment of respiratory diseases, including allergic rhinitis, bronchial asthma, COPD and common cold, and methods of treatment.
摘要翻译： 包含抗胆碱能药和至少一种用于治疗呼吸系统疾病的白三烯抑制剂的药物组合物，包括过敏性鼻炎，支气管哮喘，COPD和感冒，以及治疗方法。
-
2.发明申请Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases 审中-公开抗胆碱能药物与4型磷酸二酯酶抑制剂的组合用于治疗呼吸系统疾病公开(公告)号：US20060251589A1
公开(公告)日：2006-11-09
申请号：US11485486
申请日：2006-07-13
申请人： Joachim Maus , Peter Cnota , Istvan Szelenyi , Beatrix Fyrnys
发明人： Joachim Maus , Peter Cnota , Istvan Szelenyi , Beatrix Fyrnys
IPC分类号： A61K31/519 , A61K9/14 , A61K31/401
CPC分类号： A61K31/44 , A61K9/0073 , A61K31/40 , A61K31/401 , A61K31/4015 , A61K31/4439 , A61K31/519 , A61K45/06 , Y10S514/826 , A61K2300/00
摘要： The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
摘要翻译： 本发明涉及吸入/口服PDE4抑制剂与吸入的抗胆碱能支气管扩张剂（毒蕈碱受体拮抗剂），优选Roflumilast或AWD-12-281和R，R-格隆溴铵的组合，用于呼吸系统疾病的症状或预防性治疗 ，特别是伴有阻塞性或炎症性疾病如慢性阻塞性肺疾病（COPD）或哮喘的患者。 它还包括将这种组合在局部施用（吸入）制剂中的应用和例如在Novolizer中的吸入装置中的应用。
-
3.发明申请Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases 审中-公开抗胆碱能药物与4型磷酸二酯酶抑制剂的组合用于治疗呼吸系统疾病公开(公告)号：US20050175547A1
公开(公告)日：2005-08-11
申请号：US11051463
申请日：2005-02-07
申请人： Joachim Maus , Peter Cnota , Istvan Szelenyi , Beatrix Fyrnys
发明人： Joachim Maus , Peter Cnota , Istvan Szelenyi , Beatrix Fyrnys
IPC分类号： A61K9/00 , A61K31/401 , A61K31/519 , A61K45/06 , A61L9/04 , A61K9/14
CPC分类号： A61K31/44 , A61K9/0073 , A61K31/40 , A61K31/401 , A61K31/4015 , A61K31/4439 , A61K31/519 , A61K45/06 , Y10S514/826 , A61K2300/00
摘要： The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
摘要翻译： 本发明涉及吸入/口服PDE4抑制剂与吸入的抗胆碱能支气管扩张剂（毒蕈碱受体拮抗剂），优选Roflumilast或AWD-12-281和R，R-格隆溴铵的组合，用于呼吸系统疾病的症状或预防性治疗 特别是那些伴有阻塞性或炎症性慢性阻塞性肺疾病（COPD）或哮喘的患者。 它还包括将这种组合在局部施用（吸入）制剂中的应用和例如在Novolizer中的吸入装置中的应用。
-
4.发明申请Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases 有权用于治疗呼吸系统疾病的抗胆碱和β-模拟物的新型组合公开(公告)号：US20070270481A1
公开(公告)日：2007-11-22
申请号：US11882109
申请日：2007-07-30
申请人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
发明人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
IPC分类号： A61K31/4015 , A61P11/00
CPC分类号： A61K45/06 , A61K9/0075 , A61K9/008 , A61K31/138 , A61K31/167 , A61K31/401 , A61K31/4015 , A61K2300/00
摘要： The present invention describes a combination of anticholinergic and β mimetics for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma. It further comprises the preparation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
摘要翻译： 本发明描述了用于治疗呼吸道疾病（包括气道炎症或阻塞性疾病如慢性阻塞性肺疾病（COPD））和哮喘的抗胆碱能和β-模拟物的组合。 其还包括在局部施用（吸入）制剂中的这种组合的制备和在例如在Novolizer中的吸入装置中的应用。
-
5.发明申请Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases 审中-公开用于治疗呼吸系统疾病的抗胆碱和β-模拟物的新型组合公开(公告)号：US20060252815A1
公开(公告)日：2006-11-09
申请号：US11483693
申请日：2006-07-11
申请人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
发明人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
IPC分类号： A61K31/401 , A61K31/137 , A61K31/165
CPC分类号： A61K45/06 , A61K9/0075 , A61K9/008 , A61K31/138 , A61K31/167 , A61K31/401 , A61K31/4015 , A61K2300/00
摘要： The present invention describes a combination of anticholinergic and β mimetics for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma. It further comprises the preparation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
摘要翻译： 本发明描述了用于治疗呼吸道疾病（包括气道炎症或阻塞性疾病如慢性阻塞性肺疾病（COPD））和哮喘的抗胆碱能和β-模拟物的组合。 其还包括在局部施用（吸入）制剂中的这种组合的制备和在例如在Novolizer中的吸入装置中的应用。
-
6.发明申请Novel combination of anticholinergics - B2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases 有权抗胆碱能药物 - B2-肾上腺素受体激动剂，抗白三烯（白三烯受体拮抗剂），用于治疗炎性疾病的糖皮质激素和/或磷酸二酯酶4抑制剂的新型组合公开(公告)号：US20070196285A1
公开(公告)日：2007-08-23
申请号：US11642967
申请日：2006-12-21
申请人： Joachim Maus , Horst Kastrup , Istvan Szelenyi , Peter Cnota , Artur Bauhofer
发明人： Joachim Maus , Horst Kastrup , Istvan Szelenyi , Peter Cnota , Artur Bauhofer
IPC分类号： A61K31/573 , A61K31/47 , A61K9/14 , A61K31/138 , A61K31/4015
CPC分类号： A61K31/40 , A61K9/0075 , A61K9/008 , A61K31/167 , A61K31/4015 , A61K31/58 , A61K45/06 , A61K2300/00
摘要： The invention relates to novel combinations based on anticholinergics, β2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases.
摘要翻译： 本发明涉及基于抗胆碱能药物，β2 - 肾上腺素能受体激动剂，PDE 4抑制剂，糖皮质激素和白三烯受体拮抗剂的新型组合，其制备方法及其用于治疗炎性疾病，优选 呼吸系统疾病，如支气管哮喘和慢性阻塞性肺疾病（COPD）或风湿性或自身免疫性疾病。
-
7.发明申请Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD 审中-公开组合抗胆碱能药物和糖皮质激素用于长期治疗哮喘和COPD公开(公告)号：US20050175548A1
公开(公告)日：2005-08-11
申请号：US11051468
申请日：2005-02-07
申请人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
发明人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
IPC分类号： A61K31/401 , A61K31/4015 , A61K31/56 , A61K31/573 , A61K45/06 , A61L9/04
CPC分类号： A61K31/401 , A61K31/4015 , A61K31/56 , A61K31/573 , A61K45/06 , A61K2300/00
摘要： The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
摘要翻译： 本发明描述了包含抗胆碱能成分和糖皮质激素成分的局部吸入药物制剂的组合及其在对呼吸道疾病的症状和预防性治疗中的用途，特别是阻塞性成分或潜在炎症如哮喘和慢性阻塞性肺病 （COPD）。 它还包括将这种组合在局部施用（吸入）制剂中的应用和例如在Novolizer中的吸入装置中的应用。
-
8.发明申请Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases 审中-公开用于治疗呼吸系统疾病的新型抗胆碱能药和β-模拟物的组合公开(公告)号：US20050175549A1
公开(公告)日：2005-08-11
申请号：US11051469
申请日：2005-02-07
申请人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
发明人： Joachim Goede , Joachim Maus , Peter Cnota , Istvan Szelenyi
IPC分类号： A61K9/00 , A61K31/138 , A61K31/401 , A61K45/06 , A61K9/14 , A61L9/04
CPC分类号： A61K45/06 , A61K9/0075 , A61K9/008 , A61K31/138 , A61K31/167 , A61K31/401 , A61K31/4015 , A61K2300/00
摘要： The present invention describes a combination of anticholinergic and β mimetics for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma. It further comprises the preparation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
摘要翻译： 本发明描述了用于治疗呼吸道疾病（包括气道炎症或阻塞性疾病如慢性阻塞性肺疾病（COPD））和哮喘的抗胆碱能和β-模拟物的组合。 其还包括在局部施用（吸入）制剂中的这种组合的制备和在例如在Novolizer中的吸入装置中的应用。
-
公开(公告)号：US20050137235A1
公开(公告)日：2005-06-23
申请号：US11002762
申请日：2004-12-03
申请人： Istvan Szelenyi , Joachim Maus , Peter Cnota
发明人： Istvan Szelenyi , Joachim Maus , Peter Cnota
IPC分类号： A61K31/137 , A61K31/445 , A61K31/44 , A61K31/138
CPC分类号： A61K31/137 , A61K31/445 , A61K2300/00
摘要： The subject of the present invention is to provide a combination of two centrally acting analgesics, flupirtine and tramadol, or their respective pharmaceutically acceptable salts for the treament of pain.
摘要翻译： 本发明的主题是提供两种中枢作用的止痛剂，氟吡汀和曲马多或其各自的药学上可接受的盐用于疼痛的组合。
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.03 秒)
